Adeno-Associated Virus (AAV) Gene Therapy Market, Global Outlook and Forecast 2023-2029

Report ID: MMG300352 | Category: Service & Software | Pages: 107 | Format: PDF | Published Date: December 08,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

The global Adeno-Associated Virus (AAV) Gene Therapy market was valued at US$ 1684.4 million in 2022 and is projected to reach US$ 2966.6 million by 2029, at a CAGR of 8.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Luxturna Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Adeno-Associated Virus (AAV) Gene Therapy include Creative Biolabs, Affinia Therapeutics, Spark Therapeutics, AGC Biologics, StrideBio, SIRION Biotech, Neurophth Biotechnology, Belief BioMed and BiBo Biopharma Engineering Co., LTD., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Adeno-Associated Virus (AAV) Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adeno-Associated Virus (AAV) Gene Therapy. This report contains market size and forecasts of Adeno-Associated Virus (AAV) Gene Therapy in global, including the following market information:
Global Adeno-Associated Virus (AAV) Gene Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Adeno-Associated Virus (AAV) Gene Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Adeno-Associated Virus (AAV) Gene Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Adeno-Associated Virus (AAV) Gene Therapy Market Segment Percentages, by Type, 2022 (%)
    Luxturna
    Zolgensma
    Others
Global Adeno-Associated Virus (AAV) Gene Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Adeno-Associated Virus (AAV) Gene Therapy Market Segment Percentages, by Application, 2022 (%)
    Central Nervous System Diseases
    Ocular Diseases
    Liver-directed Diseases
    Other Hereditary Diseases
Global Adeno-Associated Virus (AAV) Gene Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Adeno-Associated Virus (AAV) Gene Therapy Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adeno-Associated Virus (AAV) Gene Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Adeno-Associated Virus (AAV) Gene Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Creative Biolabs
    Affinia Therapeutics
    Spark Therapeutics
    AGC Biologics
    StrideBio
    SIRION Biotech
    Neurophth Biotechnology
    Belief BioMed
    BiBo Biopharma Engineering Co., LTD.
    Beihai Kangcheng
    PackGene Biotech
    Sarepta Therapeutics
    Carbon BioSciences
    Kelonia Therapeutics
    Roche
    Remedium Bio
Outline of Major Chapters:
Chapter 1: Introduces the definition of Adeno-Associated Virus (AAV) Gene Therapy, market overview.
Chapter 2: Global Adeno-Associated Virus (AAV) Gene Therapy market size in revenue.
Chapter 3: Detailed analysis of Adeno-Associated Virus (AAV) Gene Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Adeno-Associated Virus (AAV) Gene Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Adeno-Associated Virus (AAV) Gene Therapy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Adeno-Associated Virus (AAV) Gene Therapy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Adeno-Associated Virus (AAV) Gene Therapy Overall Market Size
    2.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size: 2022 VS 2029
    2.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Adeno-Associated Virus (AAV) Gene Therapy Players in Global Market
    3.2 Top Global Adeno-Associated Virus (AAV) Gene Therapy Companies Ranked by Revenue
    3.3 Global Adeno-Associated Virus (AAV) Gene Therapy Revenue by Companies
    3.4 Top 3 and Top 5 Adeno-Associated Virus (AAV) Gene Therapy Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Adeno-Associated Virus (AAV) Gene Therapy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Adeno-Associated Virus (AAV) Gene Therapy Players in Global Market
        3.6.1 List of Global Tier 1 Adeno-Associated Virus (AAV) Gene Therapy Companies
        3.6.2 List of Global Tier 2 and Tier 3 Adeno-Associated Virus (AAV) Gene Therapy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Markets, 2022 & 2029
        4.1.2 Luxturna
        4.1.3 Zolgensma
        4.1.4 Others
    4.2 By Type - Global Adeno-Associated Virus (AAV) Gene Therapy Revenue & Forecasts
        4.2.1 By Type - Global Adeno-Associated Virus (AAV) Gene Therapy Revenue, 2018-2023
        4.2.2 By Type - Global Adeno-Associated Virus (AAV) Gene Therapy Revenue, 2024-2029
        4.2.3 By Type - Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2022 & 2029
        5.1.2 Central Nervous System Diseases
        5.1.3 Ocular Diseases
        5.1.4 Liver-directed Diseases
        5.1.5 Other Hereditary Diseases
    5.2 By Application - Global Adeno-Associated Virus (AAV) Gene Therapy Revenue & Forecasts
        5.2.1 By Application - Global Adeno-Associated Virus (AAV) Gene Therapy Revenue, 2018-2023
        5.2.2 By Application - Global Adeno-Associated Virus (AAV) Gene Therapy Revenue, 2024-2029
        5.2.3 By Application - Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2022 & 2029
    6.2 By Region - Global Adeno-Associated Virus (AAV) Gene Therapy Revenue & Forecasts
        6.2.1 By Region - Global Adeno-Associated Virus (AAV) Gene Therapy Revenue, 2018-2023
        6.2.2 By Region - Global Adeno-Associated Virus (AAV) Gene Therapy Revenue, 2024-2029
        6.2.3 By Region - Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Adeno-Associated Virus (AAV) Gene Therapy Revenue, 2018-2029
        6.3.2 US Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2018-2029
        6.3.3 Canada Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2018-2029
        6.3.4 Mexico Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Adeno-Associated Virus (AAV) Gene Therapy Revenue, 2018-2029
        6.4.2 Germany Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2018-2029
        6.4.3 France Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2018-2029
        6.4.4 U.K. Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2018-2029
        6.4.5 Italy Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2018-2029
        6.4.6 Russia Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2018-2029
        6.4.7 Nordic Countries Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2018-2029
        6.4.8 Benelux Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Adeno-Associated Virus (AAV) Gene Therapy Revenue, 2018-2029
        6.5.2 China Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2018-2029
        6.5.3 Japan Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2018-2029
        6.5.4 South Korea Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2018-2029
        6.5.5 Southeast Asia Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2018-2029
        6.5.6 India Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Adeno-Associated Virus (AAV) Gene Therapy Revenue, 2018-2029
        6.6.2 Brazil Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2018-2029
        6.6.3 Argentina Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Revenue, 2018-2029
        6.7.2 Turkey Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2018-2029
        6.7.3 Israel Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2018-2029
        6.7.4 Saudi Arabia Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2018-2029
        6.7.5 UAE Adeno-Associated Virus (AAV) Gene Therapy Market Size, 2018-2029
7 Adeno-Associated Virus (AAV) Gene Therapy Companies Profiles
    7.1 Creative Biolabs
        7.1.1 Creative Biolabs Company Summary
        7.1.2 Creative Biolabs Business Overview
        7.1.3 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Major Product Offerings
        7.1.4 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Revenue in Global Market (2018-2023)
        7.1.5 Creative Biolabs Key News & Latest Developments
    7.2 Affinia Therapeutics
        7.2.1 Affinia Therapeutics Company Summary
        7.2.2 Affinia Therapeutics Business Overview
        7.2.3 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Major Product Offerings
        7.2.4 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue in Global Market (2018-2023)
        7.2.5 Affinia Therapeutics Key News & Latest Developments
    7.3 Spark Therapeutics
        7.3.1 Spark Therapeutics Company Summary
        7.3.2 Spark Therapeutics Business Overview
        7.3.3 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Major Product Offerings
        7.3.4 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue in Global Market (2018-2023)
        7.3.5 Spark Therapeutics Key News & Latest Developments
    7.4 AGC Biologics
        7.4.1 AGC Biologics Company Summary
        7.4.2 AGC Biologics Business Overview
        7.4.3 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Major Product Offerings
        7.4.4 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Revenue in Global Market (2018-2023)
        7.4.5 AGC Biologics Key News & Latest Developments
    7.5 StrideBio
        7.5.1 StrideBio Company Summary
        7.5.2 StrideBio Business Overview
        7.5.3 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Major Product Offerings
        7.5.4 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Revenue in Global Market (2018-2023)
        7.5.5 StrideBio Key News & Latest Developments
    7.6 SIRION Biotech
        7.6.1 SIRION Biotech Company Summary
        7.6.2 SIRION Biotech Business Overview
        7.6.3 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Major Product Offerings
        7.6.4 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue in Global Market (2018-2023)
        7.6.5 SIRION Biotech Key News & Latest Developments
    7.7 Neurophth Biotechnology
        7.7.1 Neurophth Biotechnology Company Summary
        7.7.2 Neurophth Biotechnology Business Overview
        7.7.3 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Major Product Offerings
        7.7.4 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Revenue in Global Market (2018-2023)
        7.7.5 Neurophth Biotechnology Key News & Latest Developments
    7.8 Belief BioMed
        7.8.1 Belief BioMed Company Summary
        7.8.2 Belief BioMed Business Overview
        7.8.3 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Major Product Offerings
        7.8.4 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Revenue in Global Market (2018-2023)
        7.8.5 Belief BioMed Key News & Latest Developments
    7.9 BiBo Biopharma Engineering Co., LTD.
        7.9.1 BiBo Biopharma Engineering Co., LTD. Company Summary
        7.9.2 BiBo Biopharma Engineering Co., LTD. Business Overview
        7.9.3 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Major Product Offerings
        7.9.4 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Revenue in Global Market (2018-2023)
        7.9.5 BiBo Biopharma Engineering Co., LTD. Key News & Latest Developments
    7.10 Beihai Kangcheng
        7.10.1 Beihai Kangcheng Company Summary
        7.10.2 Beihai Kangcheng Business Overview
        7.10.3 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Major Product Offerings
        7.10.4 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Revenue in Global Market (2018-2023)
        7.10.5 Beihai Kangcheng Key News & Latest Developments
    7.11 PackGene Biotech
        7.11.1 PackGene Biotech Company Summary
        7.11.2 PackGene Biotech Business Overview
        7.11.3 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Major Product Offerings
        7.11.4 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue in Global Market (2018-2023)
        7.11.5 PackGene Biotech Key News & Latest Developments
    7.12 Sarepta Therapeutics
        7.12.1 Sarepta Therapeutics Company Summary
        7.12.2 Sarepta Therapeutics Business Overview
        7.12.3 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Major Product Offerings
        7.12.4 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue in Global Market (2018-2023)
        7.12.5 Sarepta Therapeutics Key News & Latest Developments
    7.13 Carbon BioSciences
        7.13.1 Carbon BioSciences Company Summary
        7.13.2 Carbon BioSciences Business Overview
        7.13.3 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Major Product Offerings
        7.13.4 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Revenue in Global Market (2018-2023)
        7.13.5 Carbon BioSciences Key News & Latest Developments
    7.14 Kelonia Therapeutics
        7.14.1 Kelonia Therapeutics Company Summary
        7.14.2 Kelonia Therapeutics Business Overview
        7.14.3 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Major Product Offerings
        7.14.4 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue in Global Market (2018-2023)
        7.14.5 Kelonia Therapeutics Key News & Latest Developments
    7.15 Roche
        7.15.1 Roche Company Summary
        7.15.2 Roche Business Overview
        7.15.3 Roche Adeno-Associated Virus (AAV) Gene Therapy Major Product Offerings
        7.15.4 Roche Adeno-Associated Virus (AAV) Gene Therapy Revenue in Global Market (2018-2023)
        7.15.5 Roche Key News & Latest Developments
    7.16 Remedium Bio
        7.16.1 Remedium Bio Company Summary
        7.16.2 Remedium Bio Business Overview
        7.16.3 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Major Product Offerings
        7.16.4 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Revenue in Global Market (2018-2023)
        7.16.5 Remedium Bio Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Adeno-Associated Virus (AAV) Gene Therapy Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?